Inorial

Bilastine, the active ingredient in Inorial, is a H1 receptor antagonist presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and adolescents, providing relief from nasal congestion, sneezing, itching and hives.

GNH USA supplies Inorial as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to meet global healthcare needs through reliable logistics and dedicated support teams.

Bilastine acts on the histamine H1‑receptor pathway to alleviate allergic conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea caused by seasonal or perennial allergens. Chronic idiopathic urticaria: alleviates wheals and itching associated with persistent hives. Seasonal allergic rhinitis: provides symptom relief throughout the allergy season, improving quality of life.

Bilastine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate headache reported in clinical use. - Drowsiness: occasional mild sedation, less frequent than first‑generation antihistamines. - Dry mouth: transient reduction in salivary flow causing a dry sensation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Angioedema: swelling of face, lips or throat that may compromise airway. - Stevens‑Johnson syndrome: rare severe skin eruption with blistering and mucosal involvement.

When prescribing Bilastine, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: adjust use in patients with severe renal impairment. - Avoid concomitant alcohol: may increase sedation and impair alertness. - Monitor for hypersensitivity reactions: discontinue if rash, swelling or bronchospasm occurs. - Use caution in pregnancy: limited data, prescribe only if benefit outweighs risk. - Store at room temperature: keep in original pack, protect from moisture.

Bilastine may interact with other medicines, affecting its absorption or plasma concentration.

Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibitor that can raise bilastine levels. - Erythromycin: macrolide antibiotic that may increase exposure. - Ritonavir: potent inhibitor of P‑glycoprotein and CYP3A4, raising bilastine concentrations.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium: can reduce oral absorption of bilastine. - Fruit juices (grapefruit, orange): may decrease drug bioavailability. - Other antihistamines: additive sedation or reduced efficacy.